Reference
Wu L, et al. Selpercatinib monotherapy in a Chinese patient with RET fusion/ EGFR co-mutated nonsmall cell lung cancer from the Phase II LIBRETTO-321 study: A case report. Anti-Cancer Drugs 34 : 1058-1064, No. 9, Oct 2023. Available from: URL: http://journals.lww.com/anti-cancerdrugs/pages/default.aspx
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1980, 46 (2023). https://doi.org/10.1007/s40278-023-48238-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-48238-4